MeCure Industries Plc Unveils N10 Billion Commercial Paper at 21% Yield

MeCure Industries Plc has introduced a N10 billion commercial paper programme, offering investors a 21 percent yield as part of efforts to strengthen its working capital and support ongoing expansion across the healthcare and pharmaceutical value chain. The company said the issuance reflects its broader strategy to deepen liquidity, meet rising market demand and position itself more competitively within Nigeria’s fast-growing medical sector.
According to details released by the firm, the commercial paper forms part of its long-term funding plan aimed at boosting production capacity and enhancing distribution efficiency. The management noted that the strong investor interest recorded during the launch underscores renewed confidence in the company’s performance outlook, credit profile and future growth prospects.
MeCure further explained that proceeds from the issuance will be directed toward accelerating key operational initiatives, particularly those that support the availability of quality pharmaceutical products and medical services across the country. The company described the 21 percent yield as a reflection of prevailing market conditions, while assuring that the instrument offers a stable and attractive option for institutional and retail investors seeking short-term investment opportunities.
The launch of the commercial paper adds to MeCure’s ongoing efforts to reinforce its financial base and sustain its expansion drive within the Nigerian healthcare landscape, a sector experiencing increasing demand for reliable and affordable medical solutions.



